Optos / Nikon

Nikon Healthcare provides solutions in the fields of biological science and medical using core technologies of optical and image processing technologies.  

Optos, a division of Nikon, is a global leading provider of eyecare solutions with an ultra-widefield retinal imaging device that produces images covering 82% or 200°of the retina, in a single capture in less than ½ second. 

SPAM ALERT
Please note that “Global Travel Experts” is NOT an appointed travel agency of APVRS, and has no affiliation with the APVRS. Please ignore all the emails and don't disclose any information to “Global Travel Experts”. Please contact the APVRS Secretariat should you have any questions or require any assistance.
SPAM ALERT
Please note that “Global Travel Experts” is NOT an appointed travel agency of APVRS, and has no affiliation with the APVRS. Please ignore all the emails and don't disclose any information to “Global Travel Experts”. Please contact the APVRS Secretariat should you have any questions or require any assistance.
Please join Bayer Symposia!
Don’t miss today’s and tomorrow’s Bayer Lunch symposia with our leading panel of experts to understand how we can further maximize outcomes for our DME and nAMD patients!
Please join Bayer Symposia!
Don’t miss today’s and tomorrow’s Bayer Lunch symposia with our leading panel of experts to understand how we can further maximize outcomes for our DME and nAMD patients!
Join the experts @Hall 5G now!
Don’t miss today’s Bayer Lunch symposium “Aflibercept: Achieving Optimal Outcomes in Retinal Diseases” from 12:30 to 1:30pm at Hall 5G now!
Join the experts @Hall 5G now!
Don’t miss today’s Bayer Lunch symposium “Aflibercept: Achieving Optimal Outcomes in Retinal Diseases” from 12:30 to 1:30pm at Hall 5G now!
Join the experts @S421 now!
Don’t miss today’s Bayer Lunch symposium “Maximizing Patient Outcomes in nAMD, and Can We Go Further with Disease Control?” from 12:30 to 1:30pm at S421 now!
Join the experts @S421 now!
Don’t miss today’s Bayer Lunch symposium “Maximizing Patient Outcomes in nAMD, and Can We Go Further with Disease Control?” from 12:30 to 1:30pm at S421 now!